Resources

Your selections:

Clear all

Show Filters

We found 247 resources that match your search.

GSK1265744 (Cabotegravir)

Document Date:

Guidelines for Electronic Submissions Via Email-EPR Guidelines

Guidelines for Electronic Submissions Via Email-EPR Guidelines

Document Date:

HEC Placebo Gel

Hepatitis B Vaccine Recombinant (Engerix-B)

Document Date:

Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B)

Document Date:

Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) Investigator's Brochure

Document Date:

High Level Summary of Changes for the Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0

The Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0 contains a number of changes detailed below when compared with the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0 – December 2004 (…

Document Date:

HIV-1 Multiantigen pDNA Vaccine and Human IL-12 pDNA

Document Date:

HPTN - Expedited Reporting to DAIDS and DAERS Refresher

.zip files contains Presentation to HPTN/IMPAACT Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course Expedited reporting via DAERS - Case Study

Document Date:

HVTN - Expedited Reporting to DAIDS and DAERS Refresher

.zip file contains: Presentation to HVTN Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course; Expedited reporting via DAERS - Case Study

Document Date:

Hydroxychloroquine Sulfate Package Insert

Document Date:

IBC RAC Guidance

Guidance and requirements for daids-supported research involving recombinant DNA.

Document Date:

IHV01

Document Date:

Imatinib Mesylate Package Insert

Document Date:

IMPAACT - Expedited Reporting to DAIDS and DAERS Refresher

.zip files contains: Safety training presentation on expedited reporting to DAIDS and a refresher on DAERS Case study handout Meeting for HPTN and IMPAACT networks was held June 2016.

Document Date:

IND Protocol Lists

List of IND protocols having CRF/Pharmacy records that will not be stored by DAIDS.

Document Date:

Instructions for Authorization and Transfer of CRFs and Pharmacy Records to the DAIDS RSC

Document Date:

Instructions for Authorization and Transfer of CRFs and Pharmacy Records to the DAIDS RSC

Instructions for the transfer of case report forms, (CRF) and pharmacy records to the DAIDS regulatory support center, (DAIDS RSC).

Document Date:

Instructions Page for the DAIDS Protocol Specific Informed Consent Template 2/23/2016

Informed Consent documents are in the process of being updated to be compliant with the revised Common Rule.

Document Date:

Instructions Page for the DAIDS Protocol Specific Informed Consent Template 7/24/2013

DAIDS protocol specific informed consent template—general use.

Document Date:

Instructions Page for the DAIDS Sample Informed Consent Template - Stored samples and Associated Health Information for future Research Use

Informed Consent documents are in the process of being updated to be compliant with the revised Common Rule.

Document Date:

Intralipid

Document Date:

Isentress (raltegravir) Tablets, oral suspension, Package Insert

ISENTRESS is a human immunodeficiency virus integrase strand transfer inhibitor (HIV-1 INSTI) indicated: * In combination with other antiretroviral agents for the treatment of HIV-1 infection in patients 4 weeks of age and older (1). The use of other active agents with ISENTRESS is associated with…

Document Date:

Isoniazid Package Insert

Document Date:

Isoniazid Tablet Package Insert

Document Date: